American Battery Technology Company Announces Contract to Sell Legacy Property in Fernley, Nevada — Neutral
ABAT GlobeNewsWire — April 04, 2025Sale Will Support Commercialization of Additional Advanced Technologies at its Operational Commercial-Scale Battery Recycling Facility in McCarran, Nevada Sale Will Support Commercialization of Additional Advanced Technologies at its Operational Commercial-Scale Battery Recycling Facility in McCarran, Nevada

Are Short Sellers Wrong About These 3 Semiconductor Stocks? — Positive
INDI PI RGTI MarketBeat — April 04, 2025Three U.S. chip stocks have 25% or more of their floated shares sold short, indicating a very high level of bearish sentiment among a certain group of investors.

Best Stock to Buy Right Now: Amazon vs. Home Depot — Neutral
AMZN HD The Motley Fool — April 04, 2025There's a lot of uncertainty in the stock market right now, and it's causing many investors to reconsider some of their stocks and look at which ones might offer good opportunities to buy. With U.S. President Donald Trump's ongoing tariff actions against trade partners and some economists increasing their estimates of a potential recession, it's no surprise that investors are taking a more skeptical approach to each stock they buy.

Levi & Korsinsky Reminds Zynex, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 19, 2025 - ZYXI — Neutral
ZYXI Accesswire — April 04, 2025NEW YORK, NY / ACCESS Newswire / April 4, 2025 / If you suffered a loss on your Zynex, Inc. (NASDAQ:ZYXI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/zynex-inc-lawsuit-submission-form?prid=140962&wire=1 or contact Joseph E. Levi, Esq.

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Fluence Energy, Inc. (FLNC) Shareholders — Neutral
FLNC Accesswire — April 04, 2025NEW YORK, NY / ACCESS Newswire / April 4, 2025 / If you suffered a loss on your Fluence Energy, Inc. (NASDAQ:FLNC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fluence-energy-lawsuit-submission-form?prid=140961&wire=1 or contact Joseph E. Levi, Esq.

How To Earn $500 A Month From Levi Strauss Stock Ahead Of Q1 Earnings — Neutral
LEVI Benzinga — April 04, 2025Levi Strauss & Co. LEVI will release its first-quarter earnings results after the closing bell on Monday, April 7.

CLASS ACTION REMINDER: Berger Montague Advises Rocket Lab USA (NASDAQ: RKLB) Investors to Inquire About a Securities Fraud Lawsuit by April 28, 2025 — Neutral
RKLB PRNewsWire — April 04, 2025PHILADELPHIA , April 4, 2025 /PRNewswire/ -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Rocket Lab USA, Inc. ("Rocket Lab" or the "Company") (NASDAQ: RKLB) on behalf of purchasers of Rocket Lab securities between November 12, 2024 through February 25, 2025, inclusive (the "Class Period"). Investor Deadline: Investors who purchased or acquired ROCKET LAB securities during the Class Period may, no later than APRIL 28, 2025 , seek to be appointed as a lead plaintiff representative of the class.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, shared the following update related to ELEVIDYS (delandistrogene moxeparvovec-rokl), the only approved gene therapy in patients with Duchenne muscular dystrophy. Following the safety update on acute liver failure that was issued on March 18, European Union (EU) reference member country authorities requested that the independent data monitoring committee (DMC).

INTC, AMD and AVGO Forecast – Chip Stocks Falling with Everything Else — Positive
AMD AVGO INTC FXEmpire — April 04, 2025The three chip manufacturers in this analysis are all falling right along with everything else on Wall Street, despite the news that Intel and Taiwan Semiconductor are reaching a preliminary agreement on production in the US.

Gold prices trading below $3,100 after U.S. economy created 228K jobs in March — Neutral
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL UGL Kitco — April 04, 2025Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include covering territorial and federal politics in Nunavut, Canada.

Why FuboTV Stock Soared 132% in Q1 While the S&P 500 Had Its Worst Quarter Since 2022 — Neutral
FUBO The Motley Fool — April 04, 2025In contrast with the S&P 500 index's worst quarterly performance since the bear market of early 2022, share prices of streaming television service FuboTV (FUBO -4.44%) rose 132% in Q1. This strength turns heads, particularly when the overall market struggles.

Toy prices could jump 50% following Trump's tariffs on China, Vietnam — Negative
FNKO HAS MAT CNBC — April 04, 2025Toy prices could spike exponentially after President Donald Trump levied massive tariffs against China and Vietnam. The two nations are biggest manufacturers of toys imported into the United States.

GameStop Corp (NYSE:GME) shares edged higher before Friday's opening bell on the news that CEO Ryan Cohen has purchased additional shares of the video game retailer. Cohen purchased 500,000 additional shares at $21.55 each for a total of $10.8 million, a regulatory filing showed.

Spotify royalty payouts to Nigerian, South African artists boom in 2024 — Positive
SPOT Reuters — April 04, 2025Audio streaming giant Spotify's royalty payments to artists from Nigeria and South Africa - its two biggest African markets - spiked to around $59 million last year as performers rode a wave of growing interest in music from the continent.

CLASS ACTION REMINDER: Berger Montague Advises Fluence Energy (NASDAQ: FLNC) Investors to Inquire About a Securities Fraud Lawsuit by May 12, 2025 — Neutral
FLNC PRNewsWire — April 04, 2025PHILADELPHIA , April 4, 2025 /PRNewswire/ -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Fluence Energy, Inc. ("Fluence" or the "Company") (NASDAQ: FLNC) on behalf of purchasers of Fluence securities between November 29, 2023 through February 10, 2025, inclusive (the "Class Period"). Investor Deadline: Investors who purchased or acquired Fluence securities during the Class Period may, no later than MAY 12, 2025 , seek to be appointed as a lead plaintiff representative of the class.

Gold (XAUUSD) Price Forecast: Margin Calls Trigger Liquidation, Is $3000 the Next Target? — Negative
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL UGL FXEmpire — April 04, 2025Forced selling hits gold prices, yet Fed uncertainty and rising recession odds may fuel the next gold rally above the $3111 pivot.

As the first quarter of 2025 wrapped up, the initial wave of optimism that carried markets into the new year had largely faded. Stocks opened strong, fueled by momentum from the late 2024 post-election rally, but the broader market lost ground as trade war fears and economic uncertainty weighed heavily on sentiment.

Zynex, Inc. Shareholders Who Lost Money on Their Investment are Encouraged to Contact Johnson Fistel about the Class Action Lawsuit — Neutral
FLNC ZYXI GlobeNewsWire — April 04, 2025SAN DIEGO, April 04, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP announces that a class action lawsuit has commenced on behalf of investors of Zynex, Inc. (NASDAQ: ZYXI). The lawsuit seeks to recover losses on behalf of investors who acquired their securities between March 13, 2023 and March 11, 2025, both dates inclusive (the "Class Period"). If you wish to serve as lead plaintiff, you must move the Court no later than May 19, 2025.

SRPT Stock Down After EMA Places Clinical Hold on DMD Gene Therapy — Neutral
SRPT Zacks Investment Research — April 04, 2025Shares of Sarepta Therapeutics SRPT dropped more than 6% yesterday after the EMA placed a clinical hold on all studies evaluating Elevidys, its one-shot gene therapy for Duchenne muscular dystrophy (DMD). The therapy has been developed in collaboration with pharma giant Roche RHHBY.
